Inthera Bioscience Company
Inthera Bioscience is a Switzerland-based private biopharmaceutical company developing targeted small molecule therapies for solid tumors. It is focused on developing inhibitors of intracellular protein-protein interactions employing a proprietary technology platform.
The company is headquartered in Zürich, Switzerland.
Headquarters:
Schlieren, Zurich, Switzerland, Europe
Founded Date:
2013-01-01
Industry:
Drug Discovery & Development
Employee Number:
11-50
Super Industry:
Biopharma & Life Science Tools
Investors:
Aglaia BioMedical Ventures, EVA Basel, M Ventures, Microsoft Accelerator, Novo Holdings
Ipo Status:
private
City:
Schlieren
Region:
Zurich
Country:
Switzerland
Founders:
Ulrich Kessler